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Key PointsMice lacking the System x~c~ ^−^ (Sx~c~ ^−^) transporter are resistant to pentylenetetrazole (PTZ) kindling as compared to wild‐type littermatesBasal levels of Sx~c~ ^−^ pression appear to be sufficient to facilitate kindling in wild‐type miceSx~c~null mice have reduced expression of the GluA1 AMPA receptor subunit in cortical plasma membrane

2. INTRODUCTION {#epi412307-sec-0006}
===============

System x~c~ ^−^ (Sx~c~ ^−^) is a sodium‐independent anionic amino acid antiporter comprising 2 protein components linked via a disulfide bridge: xCT (encoded by *SLC7A11*), the light chain that confers substrate specificity, and 4f2hc (encoded by *SLC3A2*), the associated glycoprotein heavy chain that traffics xCT to the plasma membrane.[1](#epi412307-bib-0001){ref-type="ref"}, [2](#epi412307-bib-0002){ref-type="ref"} Although xCT expression is inducible in a number of tissues, its constitutive expression is limited to the central nervous system (CNS) and lymphoid organs, including the thymus and spleen.[3](#epi412307-bib-0003){ref-type="ref"}, [4](#epi412307-bib-0004){ref-type="ref"} Within the CNS, xCT is detected in most major brain regions, with studies investigating its cellular source demonstrating that it is predominantly of astrocytic origin.[5](#epi412307-bib-0005){ref-type="ref"}, [6](#epi412307-bib-0006){ref-type="ref"}

Sx~c~ ^−^ imports cystine (CySS) and exports glutamate (Glu) with 1:1 stoichiometry across the cellular plasma membrane.[7](#epi412307-bib-0007){ref-type="ref"} Early functional characterization of Sx~c~ ^−^ established its fundamental physiologic role as a cellular CySS supplier. Following Sx~c~ ^−^‐mediated uptake, CySS is rapidly reduced to cysteine (Cys), a critical component of many structural, catalytic, and regulatory domains of proteins and a precursor to the essential thiol antioxidant, glutathione (GSH).[8](#epi412307-bib-0008){ref-type="ref"} Cys is also directly exported from the cell via neutral amino acid transporters.[9](#epi412307-bib-0009){ref-type="ref"} Thus, Sx~c~ ^−^ regulates intracellular and extracellular thiol redox systems.[8](#epi412307-bib-0008){ref-type="ref"}, [9](#epi412307-bib-0009){ref-type="ref"} In addition, several studies have determined that Sx~c~ ^−^ contributes significantly to the ambient extracellular Glu that bathes the CNS in vivo.[10](#epi412307-bib-0010){ref-type="ref"}, [11](#epi412307-bib-0011){ref-type="ref"}, [12](#epi412307-bib-0012){ref-type="ref"}

Alterations in redox homeostasis adversely affect neuronal synaptic plasticity,[13](#epi412307-bib-0013){ref-type="ref"}, [14](#epi412307-bib-0014){ref-type="ref"} stressing the importance of redox balance in the normal function of brain network activity. In addition, Glu released from astrocytes is known to modulate neuronal excitability and enhance synaptic strength (for review see Ref. [15](#epi412307-bib-0015){ref-type="ref"}). Furthermore, multiple studies demonstrate that changes in redox balance and/or extracellular Glu levels could be permissive in generating ictal activity. For example, mice under chronic oxidative stress show increased incidence of spontaneous and handling‐induced seizures, which occurs in association with decreased expression of the glial Glu transporters glutamate transporter 1 (GLT‐1) and glutamate aspartate transporter (GLAST).[16](#epi412307-bib-0016){ref-type="ref"} Diminished Glu uptake in mice null for the Glu transporters GLT‐1 or GLAST occurs in association with spontaneous seizures or prolonged seizure duration in an amygdaloid kindling model, respectively.[17](#epi412307-bib-0017){ref-type="ref"}, [18](#epi412307-bib-0018){ref-type="ref"} Moreover, increased Sx~c~ ^−^‐mediated cystine/glutamate exchange in glioma[19](#epi412307-bib-0019){ref-type="ref"} occurs in association with elevated Glu levels,[20](#epi412307-bib-0020){ref-type="ref"} and pharmacologic inhibition of Sx~c~ ^−^ reduces peritumoral Glu levels in patients with human glioblastoma[21](#epi412307-bib-0021){ref-type="ref"} as well as seizure frequency in glioma‐bearing mice.[22](#epi412307-bib-0022){ref-type="ref"} Whether Sx~c~ ^−^ is involved in non--tumor‐associated seizure generation is not known, although xCT levels are upregulated in hippocampi resected from patients with temporal lobe epilepsy.[23](#epi412307-bib-0023){ref-type="ref"} Finally, transgenic xCT null mice require an elevated dose of pilocarpine or kainic acid to elicit behavioral seizures---in addition to demonstrating decreased seizure severity and mortality in response to an acute dose of *N*‐methyl‐[d]{.smallcaps}‐aspartate (NMDA)---suggesting that Sx~c~ ^−^ signaling is permissive in generating acute seizure activity.[10](#epi412307-bib-0010){ref-type="ref"}

The dual regulation of redox systems and Glu homeostasis by Sx~c~ ^−^ and the potential for alterations in such to regulate brain ictal activity prompted our interest in the possibility that this antiporter may also contribute to the aberrant changes that predispose the CNS to develop epilepsy.

Kindling, a model of epileptogenesis, is the time‐dependent sensitization of neuronal circuitry that results in a decrease in convulsive seizure threshold such that a normally nonconvulsive stimulus through repeated administration eventually elicits behavioral convulsions. In the seminal kindling studies performed by Goddard, the stimulus was a subconvulsive electrical current, delivered daily via depth electrodes implanted in rat amygdala.[24](#epi412307-bib-0024){ref-type="ref"} Later, studies pioneered the use of systemic administration of subconvulsive doses of pentylenetetrazole (PTZ).[25](#epi412307-bib-0025){ref-type="ref"}, [26](#epi412307-bib-0026){ref-type="ref"} Thus, the overall goal of this study was to explore the contribution of Sx~c~ ^−^ to epileptogenesis by comparing PTZ kindling in mice wild‐type or null for the *SLC7A11* gene.

3. METHODS {#epi412307-sec-0007}
==========

3.1. Animal husbandry {#epi412307-sec-0008}
---------------------

Mice were maintained in the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) accredited laboratory animal resource facility of Syracuse University on a 12‐hour light/dark schedule (7 [am]{.smallcaps}/7 [pm]{.smallcaps}). Standard mouse chow and water were provided ad libitum. Experiments were carried out using male mice (8‐12 weeks at start of experimentation) in accordance with the National Institutes of Health Guide for Care and Use of Laboratory Animals as approved by the Syracuse University Institutional Animal Care and Use Committee. Purchased C57BL/6J mice (Jackson Laboratories \[JAX\] Stock \#000664) were allowed to acclimatize to the facility for at least 1 week before any manipulations. Wild‐type (*SLC7A11* ^*+/+*^) and xCT mutant (*SLC7A11* ^*sut/sut*^) mice were bred in‐house from heterozygous (*SLC7A11* ^*+/sut*^) breeding units (F1) that were obtained by crossing *SLC7A11* ^*sut/sut*^ male mice (JAX, Stock \#001310) with *SLC7A11* ^*+/+*^ female C3H/HeSnJ mice (JAX, Stock \#000661). F2 *SLC7A11* ^*+/sut*^ progeny were also used as breeding units for studies. Genotyping was performed via polymerase chain reaction (PCR) analysis of tail genomic DNA samples: *+/+* primers, 5′‐GAA GTG CTC CGT GAA GG‐3′ (forward), 5′‐ATC TCA ATC CTG GGC AGA TG‐3′ (reverse); *sut/sut* primers, 5′‐CCA CTG TTG TAG GTC AGC TTA GG‐3′ (forward), 5′‐CAG GAC CTG TGA ATA TGA TAG GG‐3′ (reverse). Mice were segregated by sex at weaning and placed 2 to 3 per cage such that at least one mouse of each genotype was represented. These breeding and housing strategies were employed to control for environmental differences, genetic background influences, and genetic drift. Gross morphologic analysis of *SLC7A11* ^*sut/sut*^ and *SLC7A11* ^*+/+*^ male mouse brains at 12 weeks of age revealed no significant differences (not shown).

3.2. Pentylenetetrazole kindling {#epi412307-sec-0009}
--------------------------------

Five days before each study, mice were acclimated to handling by performing mock daily intraperitoneal (i.p.) injections, which consisted of inverting the mouse and rubbing its abdomen. They were also acclimatized to the procedure room for at least 1 hour on each day of injection. PTZ (Sigma Chemical Co., St. Louis, MO), made fresh daily, was dissolved in saline and filter sterilized, and it was administered intraperitoneally (i.p.) in a volume of 10 mL/kg body weight. C3H/HeSnJ or C57BL/6J mice were treated with a dose of 35 or 39 mg/kg, respectively, once daily for up to 21 days. These doses were chosen for each strain because in initial dose‐ranging studies performed in wild‐type mice only (this study and Ref. [27](#epi412307-bib-0027){ref-type="ref"} respectively), they produced a mean maximal acute seizure score of 2 (see scoring criteria described below). Following each injection, mice were monitored for 30 minutes and the time and severity of behavioral seizures scored and recorded by an observer blinded to genotype using a 5‐point modified Racine scale (0‐4: 0 = no behavioral change; 1 = hypoactivity; 2 = myoclonus; 3 = generalized convulsion with righting reflex; 4 = generalized convulsion with loss of righting reflex).[28](#epi412307-bib-0028){ref-type="ref"} Six of 24 *SLC7A11* ^*sut/sut*^ vs 0/27 *SLC7A11* ^*+/+*^ (*P *=* *0.01, Fisher exact test)---were a priori excluded from the study because they responded to the first injection with a convulsive seizure (stage 3 or greater) making any further reduction in seizure threshold elicited by the kindling protocol indeterminable. Mice were deemed kindled after exhibiting convulsive seizures (stage 3 or greater) on 3 consecutive days, after which PTZ injections were stopped. Ten days later, the permanence of the kindled state was assessed by rechallenging with PTZ. A schematic of this experimental design is depicted in Figure [S1](#epi412307-sup-0001){ref-type="supplementary-material"}. The percentage of permanently kindled mice was determined by dividing the number of animals with a maximum seizure score ≥3 by the total number of animals injected.

3.3. Real‐time quantitative polymerase chain reaction {#epi412307-sec-0010}
-----------------------------------------------------

The neocortex and dorsal hippocampus were dissected from PTZ‐kindled, PTZ‐nonkindled, or saline‐injected C57BL/6J mice 1 day following the final injection with PTZ or saline, placed in TRIzol reagent (Invitrogen, Carlsbad, CA), and stored at −80°C. Following synthesis of first‐strand complementary DNA (cDNA) from total RNA, real‐time quantitative PCR (qPCR) was performed using mouse‐specific primers for xCT (*SLC7A11*, Mm01292531_m1, TaqMan Gene Expression Assays, Applied Biosystems, Foster City, CA) and the reference gene hypoxanthine guanine phosphoribosyl transferase (*HPRT*, Mm01545399_m1, TaqMan Gene Expression Assays, Applied Biosystems) along with TaqMan Universal PCR MasterMix (Applied Biosystems). HPRT expression levels were stable under our experimental conditions. A serial dilution of cortical or hippocampal cDNA demonstrated that the calculated slope of the line comparing ∆*C* ~T~ (*C* ~T~ value of xCT − *C* ~T~ value of HPRT) vs input cDNA was −0.007606 or −0.000905, respectively, and that the efficiency of both primers was \>90% in either tissue. Reactions were performed in duplicate or triplicate using an Eppendorf Realplex[2](#epi412307-bib-0002){ref-type="ref"} under the following conditions: 50°C for 2 minutes and 95°C for 10 minutes followed by 40 amplification cycles (95°C for 15 seconds and 60°C for 1 minute). Data analysis was performed using the comparative cycle threshold method (∆∆*C* ~T~), where *C* ~T~ values of xCT were normalized to HPRT *C* ~T~ values from the same sample and compared to the calibrator *C* ~T~ values (saline controls) to determine the relative fold increase in xCT mRNA.

3.4. Timm and thionin staining {#epi412307-sec-0011}
------------------------------

Mossy fiber sprouting, elucidated by Timm staining, was quantified in the supragranular layer of the dentate gyrus (DG) by an observer blinded to the experimental condition. Brain slices from PTZ kindled *SLC7A11* ^*+/+*^ and *SLC7A11* ^*sut/sut*^ mice and saline‐injected *SLC7A11* ^*+/+*^ mice were sacrificed 16‐17 days after kindling acquisition or cessation of saline injections by transcardial perfusion with a proprietary (FD Rapid TimmStain Kit; FD Neuro Technologies, Inc., Baltimore, MD) sodium sulfide‐containing perfusate, followed by 4% paraformaldehyde (PFA) in 0.1 M phosphate buffer (PB). Brains were postfixed in 4% PFA for 24 hours (4°C), transferred to a 30% sucrose solution in 0.1 M PB for 72 hours (4°C), and then snap‐frozen on dry ice in Optimal Cutting Temperature (O.C.T.) compound (Tissue‐Tek, Torrance, CA) prior to storage at −80°C. Frozen brains were cut serially (≈−0.94 to −2.46 mm posterior to bregma) into 40‐μm coronal sections, mounted on gelatin‐coated slides, air dried at room temperature for 24 hours, and then stored in a light‐protected box at −20°C. Timm staining was carried out per manufacturer\'s instructions (FD Rapid TimmStain Kit), with the exception that the time in the silver nitrate developing solution was extended to 55‐70 minutes. Mossy fiber sprouting was quantified using a 6‐point rating scale (0‐5) developed by Cavazos et al[29](#epi412307-bib-0029){ref-type="ref"}: 0 = no Timm granules; 1 = patchy distribution of sparse granules in supragranular layer; 2 = continuous distribution of granules in supragranular layer; 3 = continuous distribution of granules with patches of confluency in supragranular layer; 4 = prominent granules that form a dense, confluent laminar band in supragranular layer; and 5 = prominent granules that form a dense, confluent laminar band in the supragranular layer that extend into the inner molecular layer. A Timm score for each mouse was determined by calculating the median of the scores assigned to the left and right dentate gyrus (DG) at ≈−1.94 mm posterior to bregma. Tissue sections within 80 μm of those processed for Timm staining were thionin‐stained (Sigma Chemical Co.) as we described previously to assess for any neurodegeneration. All tissue analyses were performed on identically processed photomicrographs acquired using a DP73 digital color camera (Olympus, Tokyo, Japan) mounted on an Olympus IX50 inverted microscope (Olympus).

3.5. Reduced/Oxidized glutathione and cysteine measurements {#epi412307-sec-0012}
-----------------------------------------------------------

Fully anesthetized naive *SLC7A11* ^*+/+*^ or *SLC7A11* ^*sut/sut*^ mice were perfused transcardially with ice‐cold phosphate buffered saline (PBS). The dorsal hippocampus and neocortex were rapidly dissected and snap‐frozen separately in liquid nitrogen. The concentrations of reduced and oxidized glutathione (GSH and GSSG) and cysteine (Cys and CySS) were determined via high‐performance liquid chromatography (HPLC) by the Emory‐Children\'s Pediatric Biomarkers Core facility.

3.6. Immunoblotting {#epi412307-sec-0013}
-------------------

### 3.6.1. Plasma membrane protein isolation {#epi412307-sec-0014}

Naive *SLC7A11* ^*+/+*^ or *SLC7A11* ^*sut/sut*^ mice were perfused transcardially with ice‐cold 1× PBS under full anesthesia. Bilateral dorsal hippocampi and neocortices were dissected, snap‐frozen in liquid nitrogen separately, and stored at −80°C prior to use. Plasma membrane proteins were isolated from pooled hippocampi (2‐5 mice/sample) or bilateral cortices (one mouse/sample) using an aqueous 2‐phase separation method as per manufacturer\'s instructions (Plasma Membrane Protein Extraction Kit; Abcam, Cambridge, UK). Isolated proteins were suspended in 0.5% Triton X‐100 in PBS. Samples were stored at −80°C until immunoblotting. Protein concentrations were quantified using the BCA assay kit (Pierce, Rockford, IL).

### 3.6.2. Gel electrophoresis and protein detection {#epi412307-sec-0015}

Protein samples (7.5 μg) were separated by 8% Sodium Dodecyl Sulfate Polyacrylamide gel electrophoresis (SDS‐PAGE) under reducing (10 mM dithiothreitol) and chaotropic (8 M urea) conditions followed by electrophoretic transfer to a polyvinylidene difluoride (PVDF) membrane (Bio‐Rad, Hercules, CA). Membranes were blocked for 1 hour at room temperature (Odyssey blocking buffer, LI‐COR Biosciences; Lincoln, NE) and then probed overnight (4°C) with the mouse monoclonal loading control anti‐Na^+^/K^+^ ATPase α1 antibody (1:750; Abcam; RRID: [AB_306023](https://scicrunch.org/resolver/AB_306023)) in addition to one of the following antibodies: anti‐GluA1 rabbit polyclonal antibody (1:750; Abcam; RRID: [AB_2113447](https://scicrunch.org/resolver/AB_2113447)); anti‐GluA2 rabbit polyclonal antibody (1:750; Abcam; RRID: [AB_2232655](https://scicrunch.org/resolver/AB_2232655)); anti‐GluN1 rabbit monoclonal antibody (1:750; Cell Signaling; RRID: [AB_1904067](https://scicrunch.org/resolver/AB_1904067)); anti‐GluN2A rabbit polyclonal antibody (1:750; Cell Signaling; RRID: [AB_2112295](https://scicrunch.org/resolver/AB_2112295)); anti‐GluN2B rabbit polyclonal antibody (1:750; Cell Signaling; RRID: [AB_1264223](https://scicrunch.org/resolver/AB_1264223)); anti‐GABA~A~Rα1 rabbit polyclonal antibody (1:3000; Abcam; RRID: [AB_732498](https://scicrunch.org/resolver/AB_732498)); or anti‐K^+^/Cl^−^ co‐transporter (KCC2) rabbit polyclonal antibody (1:750; Abcam; RRID: [AB_881571](https://scicrunch.org/resolver/AB_881571)). Species‐specific secondary antibodies labeled with spectrally distinct IRDye fluorescent dyes (LI‐COR Biosciences) were used to detect primary antibodies (1 hour at 25°C) (1:10 000 dilution). Results were recorded on a LI‐COR ODYSSEY Fc Imaging system (LI‐COR Biosciences) and analyzed using Image Studio 3.1 (LI‐COR Biosciences). Na^+^/K^+^ ATPase is a protein constitutively expressed in plasma membrane. Thus, plasma membrane protein levels were normalized to their own respective Na^+^/K^+^ ATPase levels. The signal intensity pertaining to the amount of hippocampal or cortical protein per lane (7.5 μg) was determined to be in the linear range for each antibody at their respective dilution (data not shown).

3.7. Statistical analysis {#epi412307-sec-0016}
-------------------------

All statistical analyses were performed using GraphPad Prism (Version 6.0.1; GraphPad Software, Inc., La Jolla, CA). Curves depicting kindling acquisition as a function of time were compared using a log‐rank test. Two‐way analysis of variance (ANOVA) or unpaired *t* test was used to compare seizure latencies, mouse weight, and the concentrations of reductants/oxidants. Proportions indicating the percent of mice convulsing were compared using a Fisher exact test. The Mann‐Whitney *U* test was used to compare Timm scores. Prior to parametric analysis, qPCR data were transformed to the geometric means, whereas immunoblot data was log transformed (*y* = log\[*y* + 1\]) and compared using 1‐way ANOVA or an unpaired *t* test, respectively. In all cases, significance was set at *P *\<* *0.05.

4. RESULTS {#epi412307-sec-0017}
==========

4.1. Kindling acquisition, maintenance, and mortality {#epi412307-sec-0018}
-----------------------------------------------------

Irrespective of the mouse\'s genotype, the number of kindled mice increased steadily over the 21‐day dosing paradigm (Figure [1](#epi412307-fig-0001){ref-type="fig"}A), with the mean latency to kindle being 10.3 ± 1.1 and 11.4 ± 1.2 days for *SLC7a11* ^*+/+*^ and *SLC7a11* ^*sut/sut*^ mice, respectively (*P *=* *0.54, unpaired *t* test). Although the latency to convulsive seizure on each of the 3 consecutive days leading up to and inclusive of the kindled state was similar between *SLC7a11* ^*+/+*^ and *SLC7a11* ^*sut/sut*^ littermates (Figure [1](#epi412307-fig-0001){ref-type="fig"}B; *P *=* *0.40, 2‐way ANOVA), kindling acquisition was significantly reduced in *SLC7a11* ^*sut/sut*^ (9/18; 50%) as compared to *SLC7a11* ^*+/+*^ (22/27; 81.5%; Figure [1](#epi412307-fig-0001){ref-type="fig"}A; *P *=* *0.02, log‐rank test).

![Comparison of pentylenetetrazole (PTZ) kindling acquisition and convulsive seizure latency between SLC7A11^+/+^ and SLC7A11^*sut/sut*^ mice. *SLC7A11* ^+/+^ (+/+; closed blue circles, n = 27) and *SLC7A11* ^*sut/sut*^ (*sut/sut*; open black circles, n = 18) mice were administered 35 mg/kg PTZ (i.p.) once daily for 21 days or until the mouse became kindled. Five separate experiments were performed over 24 months. A, *Kindling acquisition*: Each data point represents the percentage of mice kindled each day over the 21 day paradigm, which was determined by dividing the number of animals defined as kindled (see [Methods](#epi412307-sec-0002){ref-type="sec"}) by the total number of animals injected. Fractions represent the proportion of mice kindled at the end of the protocol. The rate and proportion of *SLC7A11* ^*sut/sut*^ mice that kindled are significantly decreased as compared to *SLC7A11* ^*+/+*^ littermate controls as denoted by the asterisk and pound sign, respectively (\**P *=* *0.02, log‐rank test; ^\#^ *P *\<* *0.05, Fisher exact test). B, *Convulsive seizure latency*: Each data point \[closed blue circles (*+/+*) or open circles (*sut/sut*)\] represents the latency to convulsion (behavioral score ≥3) of a single mouse for each of the 3 consecutive convulsions (depicted as Convulsion 1‐3) that led to its kindled state. Bars represent the mean latency to convulsive seizure for each genotype. Kindled *SLC7A11* ^*+/+*^ and *SLC7A11* ^*sut/sut*^ mice have similar convulsive seizure latencies (*P *=* *0.40, 2‐way analysis of variance \[ANOVA\])](EPI4-4-133-g001){#epi412307-fig-0001}

Permanency of the kindled state, determined by rechallenge with PTZ 10 days after the third convulsion, was neither 100% for either genotype nor statistically significant between genotypes, with only 82% of the *SLC7a11* ^*+/+*^ (18/22) and 78% of *SLC7a11* ^*sut/sut*^ (7/9) responding to the PTZ challenge with a seizure score of ≥3 (*P *=* *1.00, Fisher exact test). The latency to convulsion upon rechallenge also did not differ between the genotypes (431 ± 45 vs 416 ± 51 s for *SLC7a11* ^*+/+*^ vs *SLC7a11* ^*sut/sut*^, respectively; *P *=* *0.85, unpaired *t* test).

Of note, no mortality occurred in either group during the kindling paradigm. Mice that completed the paradigm exhibited an average loss of 1% body weight. However, the final weight of kindled mice did not differ between genotypes (25.2 ± 0.4 vs 23.9 ± 0.5 g for *SLC7a11* ^*+/+*^ and *SLC7a11* ^*sut/sut*^, respectively), nor did these differ from that of nonkindled mice (23.2 ± 1.1 vs 24.4 ± 0.5 g for *SLC7a11* ^*+/+*^ and *SLC7a11* ^*sut/sut*^, respectively, 2‐way ANOVA).

4.2. xCT mRNA levels {#epi412307-sec-0019}
--------------------

To determine whether the kindling phenotype was associated with an increase in xCT expression, we measured hippocampal and cortical xCT mRNA levels in kindled, nonkindled, and saline‐injected *SLC7a11* ^*+/+*^ mice via quantitative PCR, 1 day following the final PTZ or saline injection. Neither hippocampal nor cortical xCT mRNA expression levels of kindled mice differed from nonkindled or saline‐administered control mice (Figure [2](#epi412307-fig-0002){ref-type="fig"}), suggesting that basal levels of Sx~c~ ^−^ are sufficient to facilitate kindling.

![Pentylenetetrazole (PTZ) kindling phenotype is not associated with alterations in Sx~c~^−^ light chain (xCT) messenger RNA (mRNA). *SLC7A11* ^*+/+*^ mice on a C57BL/6J background were administered 39 mg/kg PTZ once daily for 21 days or until kindled. Mice receiving vehicle (saline) were injected in parallel. The left hippocampus (A) and left cortex (B) were harvested 24 h following the final injection of PTZ or vehicle and xCT mRNA was assessed via quantitative polymerase chain reaction (qPCR). Data are expressed as mean ± standard error of the mean (SEM) fold‐change in xCT mRNA compared with vehicle‐injected controls. No significant between‐group differences in xCT mRNA expression in hippocampus (*P *=* *0.84) or cortex (*P *=* *0.26) was found as determined by 1‐way analysis of variance (ANOVA). N = 4‐5 each per treatment group](EPI4-4-133-g002){#epi412307-fig-0002}

4.3. Histologic analysis of injury and axonal sprouting {#epi412307-sec-0020}
-------------------------------------------------------

Sixteen to 17 days following PTZ kindling, brains were examined for signs of overt cellular degeneration. Thionin‐staining of brain slices revealed that the cortex (not shown) and principal layers of the hippocampal formation (Figure [3](#epi412307-fig-0003){ref-type="fig"}A,E,I), including the CA1 (Figure [3](#epi412307-fig-0003){ref-type="fig"}B,F,J), the CA3 (Figure [3](#epi412307-fig-0003){ref-type="fig"}C,G,K), and the dentate gyrus (DG; Figure [3](#epi412307-fig-0003){ref-type="fig"}D,H,L) of kindled mice appeared grossly normal and intact irrespective of genotype. The lack of degeneration was confirmed in adjacent sections using Fluoro‐Jade C and a 4′,6‐diamidino‐2‐phenylindole (DAPI) counterstain (data not shown). Aberrant sprouting of DG granule cell axons, known as mossy fiber sprouting, is a common feature in temporal lobe epilepsy and is found in some, but not all, rodent models of epileptogenesis. PTZ‐kindled *SLC7a11* ^*+/+*^ mice, maintained on a C3H/HeSnJ background, had few mossy fiber synaptic terminals, as evidenced by little to no Timm granules in the supragranular layer of the DG that were comparable in number to those quantified in saline‐treated control mice (Figure [4](#epi412307-fig-0004){ref-type="fig"}; median Timm score = 0.75 vs 1, respectively; *P *=* *0.69, Mann‐Whitney *U* test). *SLC7a11* ^*sut/sut*^ kindled mice also showed little to no change in mossy fiber sprouting (Figure [4](#epi412307-fig-0004){ref-type="fig"}; median Timm score = 1). Thus, alterations in mossy fiber sprouting cannot explain the reduction in kindling acquisition in *SLC7a11* ^*sut/sut*^ as compared to *SLC7a11* ^*+/+*^ mice.

![Pentylenetetrazole (PTZ) kindling phenotype is not associated with cellular degeneration. Representative photomicrographs of thionin‐stained coronal brain sections ≈−1.82 mm posterior to bregma: (A‐D) vehicle (saline)‐injected *SLC7A11* ^*+/+*^ (*+/+*; n = 3), (E‐H) kindled *SLC7A11* ^*+/+*^ (*+/+*; n = 4), and (I‐L) kindled *SLC7A11* ^*sut/sut*^ (*sut/sut*; n = 2) brain sections. Images represent the hippocampal formation (A, E, I; 8×), CA1 (B, F, J; 20×), CA3 (C, G, K; 20×), or the dentate gyrus (DG) (D, H, L; 20×)](EPI4-4-133-g003){#epi412307-fig-0003}

![Pentylenetetrazol e (PTZ) kindling phenotype is not associated with increased mossy fiber sprouting. A‐F, Representative photomicrographs of Timm‐stained hippocampal formation ≈ −1.94 mm posterior to bregma: (A‐B) vehicle (saline)‐injected control *SLC7A11* ^*+/+*^ (*+/+*; n = 3, red bar/circles), (C‐D) kindled *SLC7A11* ^*+/+*^ (*+/+*; n = 4, blue bar/circle) (C‐D), and (E‐F) kindled *SLC7A11* ^*sut/sut*^ (*sut/sut*; n = 2, black bar/circles). Images represent the hippocampal formation (A, C, E; 8×) and the DG (B, D, F; 40×). Boxes in A, C, and E depict the region of the DG assessed for mossy fiber sprouting. G, Each circle represents the Timm score (see [Methods](#epi412307-sec-0002){ref-type="sec"}) of a single mouse determined by calculating the median of the scores assigned to the right and left dentate gyrus (DG) (40×) at ≈ −1.94 mm bregma. Open bars represent the median Timm score for each group. There was no significant difference in mossy fiber sprouting between vehicle‐injected *SLC7A11* ^*+/+*^ and kindled *SLC7A11* ^*+/+*^ mice as determined by the Mann‐Whitney *U* test (*P *=* *0.69)](EPI4-4-133-g004){#epi412307-fig-0004}

4.4. Redox signaling {#epi412307-sec-0021}
--------------------

Cys derived from Sx~c~ ^−^ import of CySS is the rate‐limiting substrate for the production of the low‐molecular‐weight thiol GSH and contributes to the Cys/CySS redox couple across the cell plasma membrane.[9](#epi412307-bib-0009){ref-type="ref"}, [30](#epi412307-bib-0030){ref-type="ref"}, [31](#epi412307-bib-0031){ref-type="ref"} To determine whether loss of Sx~c~ ^−^ resulted in a redox imbalance in *SLC7a11* ^*sut/sut*^ brains, the hippocampal and cortical levels of reduced and oxidized GSH (GSH and GSSG) and Cys (Cys and CySS) were measured and compared to levels measured from *SLC7a11* ^*+/+*^ tissues. Neither GSH (Figure [5](#epi412307-fig-0005){ref-type="fig"}A left; *P *=* *0.74; Figure [5](#epi412307-fig-0005){ref-type="fig"}C left; *P *=* *0.28, unpaired *t* test) nor GSSG levels measured in either the hippocampus or cortex (Figure [5](#epi412307-fig-0005){ref-type="fig"}A right; *P *=* *0.34; Figure [5](#epi412307-fig-0005){ref-type="fig"}C right; *P *=* *0.12, unpaired *t* test) levels were different between *SLC7a11* ^*+/+*^ and *SLC7a11* ^*sut/sut*^ mice. Cortical levels of Cys were also similar between the genotypes (Figure [5](#epi412307-fig-0005){ref-type="fig"}D left; *P *=* *0.80, unpaired *t* test), whereas there was a small, but nonsignificant increase in CySS (Figure [5](#epi412307-fig-0005){ref-type="fig"}D right; *P *=* *0.12, unpaired *t* test). Notably, in the hippocampus, the level of CySS was significantly decreased in *SLC7a11* ^*sut/sut*^ mice as compared to *SLC7a11* ^*+/+*^ littermate controls (Figure [5](#epi412307-fig-0005){ref-type="fig"}B right; *P *=* *0.002, unpaired *t* test), whereas Cys levels were unchanged (Figure [5](#epi412307-fig-0005){ref-type="fig"}B left; *P *=* *1.00, unpaired *t* test).

![Comparison of redox couples in *SLC7A11* ^*+/+*^ and *SLC7A11* ^*sut/sut*^ mice. The concentration of reduced and oxidized glutathione(GSH and GSSG) or cysteine (Cys and CySS), respectively, was determined by high‐performance liquid chromatography (HPLC) in hippocampus (A‐B) or cortex (C‐D) of naive *SLC7A11* ^*+/+*^ (*+/+*; blue bars; n = 8‐10) and *SLC7A11* ^*sut/sut*^ (*sut/sut;* white bars; n = 10) littermates. Bars represent the mean ± standard error of the mean (SEM) fold‐change over control (+/+, set to one) of the concentration of hippocampal or cortical GSH (A, C; left bars), GSSG (A, C; right bars), Cys (B, D; left bars), or CySS (B, D; right bars). Comparisons between individual levels of reduced or oxidized GSH or Cys were made using an unpaired *t* test on raw data. An asterisk (\*) represents a significant between group difference (*P *=* *0.002)](EPI4-4-133-g005){#epi412307-fig-0005}

4.5. Plasma membrane protein expression levels {#epi412307-sec-0022}
----------------------------------------------

Finally, we assessed cortical and hippocampal surface expression of AMPA (GluA1, GluA2), NMDA (GluN1, GluN2A, and GluN2B), and GABA (GABA~A~Rα1) receptor subunits, as well as, the K^+^/Cl^−^ co‐transporter (KCC2) (Figure [6](#epi412307-fig-0006){ref-type="fig"}), as aberrations in plasma membrane levels of each has been associated with abnormal neuronal synchronization.[32](#epi412307-bib-0032){ref-type="ref"}, [33](#epi412307-bib-0033){ref-type="ref"}, [34](#epi412307-bib-0034){ref-type="ref"} Western blot analysis of this suite of plasma membrane proteins revealed no change in expression levels between *SLC7a11* ^*+/+*^ and *SLC7a11* ^*sut/sut*^ littermates in the hippocampus (Figure [6](#epi412307-fig-0006){ref-type="fig"}A,B). Of note, cortical levels of the AMPA receptor subunit GluA1 were significantly decreased in *SLC7a11* ^*sut/sut*^ mice as compared to *SLC7a11* ^*+/+*^ littermate controls (Figure [6](#epi412307-fig-0006){ref-type="fig"}C; *P *=* *0.01, unpaired *t* test on log transformed data). No other cortical plasma membrane proteins were altered in *SLC7a11* ^*sut/sut*^ as compared to *SLC7a11* ^*+/+*^ littermate controls (Figure [6](#epi412307-fig-0006){ref-type="fig"}C).

![Comparison of plasma membrane protein expression in *SLC7A11* ^*+/+*^ and *SLC7A11* ^*sut/sut*^ mice. Plasma membrane protein levels in hippocampus or cortex derived from *SLC7A11* ^*+/+*^ (*+/+*) or *SLC7A11* ^*sut/sut*^ (*sut/sut*) littermates were compared using western blot analysis (see [methods](#epi412307-sec-0002){ref-type="sec"}). Representative western blots of *+/+* and *sut/sut* hippocampal plasma membrane proteins are shown in A. Each data point (closed blue circles \[*+/+*; n = 7‐9\] or open black circles \[*sut/sut*; n = 5‐9\]) represents the level of hippocampal (B) or cortical (C) protein following normalization to their own respective loading control (i.e., Na^+^/K^+^ ATPase levels). Bars indicate the mean fold‐change over control (+/+), which was set to one. Hippocampal or cortical plasma membrane protein expression levels were compared using an unpaired *t* test on log‐transformed data. An asterisk (\*) represents a significant between group difference (*P *=* *0.01)](EPI4-4-133-g006){#epi412307-fig-0006}

5. DISCUSSION {#epi412307-sec-0023}
=============

By virtue of its localization to astrocytes and its role in regulating thiol redox systems as well as ambient extracellular Glu levels, Sx~c~ ^−^ (cystine/glutamate antiporter) contributes importantly to CNS homeostasis. In fact, astrocytic transporters, in general, regulate brain excitatory/inhibitory (E/I) balance by providing neurons with energy substrates, by maintaining ion homeostasis, and by removing excess neurotransmitters from the extracellular space. Dysfunction in any one of these activities can facilitate epileptogenesis (reviewed in Ref. [35](#epi412307-bib-0035){ref-type="ref"}). In this study, we provide evidence that Sx~c~ ^−^ signaling contributes to epileptogenesis in the PTZ‐kindling model of acquired epilepsy (Figure [1](#epi412307-fig-0001){ref-type="fig"}). These findings complement studies demonstrating an incontrovertible role for Sx~c~ ^−^ in glioma‐associated epilepsy in both mice and man.[21](#epi412307-bib-0021){ref-type="ref"}, [22](#epi412307-bib-0022){ref-type="ref"}

Although Sx~c~ ^−^ has been found to be upregulated in glioma,[36](#epi412307-bib-0036){ref-type="ref"} we do not find any changes in xCT mRNA expression in PTZ‐kindled mice as compared to vehicle‐injected controls (Figure [2](#epi412307-fig-0002){ref-type="fig"}), suggesting that basal levels of Sx~c~ ^−^ are sufficient to facilitate PTZ‐kindling. Given the lack of reliable commercial antibody for xCT (personal observations and Ref. [37](#epi412307-bib-0037){ref-type="ref"}), we cannot rule out the possibility that enhanced transporter trafficking (as has been described in human glioma cells in vitro[38](#epi412307-bib-0038){ref-type="ref"}) or increased transporter kinetics (as demonstrated in rat striatum in vivo[39](#epi412307-bib-0039){ref-type="ref"}) occurs in wild‐type mice. However, present data suggest that in vivo glutamatergic tone---maintained in large part by nonvesicular release of Glu by Sx~c~ ^−^ [10](#epi412307-bib-0010){ref-type="ref"}, [11](#epi412307-bib-0011){ref-type="ref"}, [12](#epi412307-bib-0012){ref-type="ref"}---may be enough to dysregulate excitatory signaling in wild‐type mice, as we previously documented in an in vitro paradigm of hypoglycemic neuronal cell death.[40](#epi412307-bib-0040){ref-type="ref"} Lending credence to this interpretation are the findings that a reduction in GABAergic inhibition[41](#epi412307-bib-0041){ref-type="ref"}, [42](#epi412307-bib-0042){ref-type="ref"} and an increase in extracellular Glu and Glu receptor levels[43](#epi412307-bib-0043){ref-type="ref"}, [44](#epi412307-bib-0044){ref-type="ref"} are associated with PTZ‐kindling in rodents. Conversely, a decrease in ambient, extracellular Glu levels has been reported in mice lacking Sx~c~ ^−^.[10](#epi412307-bib-0010){ref-type="ref"}, [11](#epi412307-bib-0011){ref-type="ref"}, [12](#epi412307-bib-0012){ref-type="ref"} This, together with the reduction in cortical GluA1 AMPA‐receptor subunit protein expression found herein (Figure [6](#epi412307-fig-0006){ref-type="fig"}), suggests that glutamatergic signaling may be hypofunctional in the *SLC7A11* ^*sut/sut*^ mouse brain in a manner sufficient to reduce PTZ kindling. In keeping with this idea, hippocampal long‐term potentiation (LTP) is also reduced in *SLC7A11* ^*sut/sut*^ mice.[45](#epi412307-bib-0045){ref-type="ref"} However, a subcohort of *SLC7A11* ^*sut/sut*^ mice in this study were a priori excluded because they responded to the first injection with a convulsive seizure (Figure [S1](#epi412307-sup-0001){ref-type="supplementary-material"}). This could simply reflect normal population biologic variability in seizure threshold or represent a true phenotypic difference. Using an acute PTZ paradigm, we hope to differentiate between these 2 possibilities. Moreover, it should be noted that enhanced synaptic GluA1 expression has been reported in the CA1 region of the hippocampus of transgenic xCT null mice,[46](#epi412307-bib-0046){ref-type="ref"} although we found no change in global hippocampal GluA1 levels in *SLC7A11* ^*sut/sut*^ mice (Figure [6](#epi412307-fig-0006){ref-type="fig"}). It is difficult to compare these 2 studies as our plasma membrane measurements include all hippocampal subregions and would capture receptors of both synaptic and extrasynaptic origin. Nevertheless, a global plasma membrane reduction in the cortical GluA1 AMPA receptor subunit is interesting given evidence that block of AMPA receptor signaling is anti‐epileptogenic in animal models.[47](#epi412307-bib-0047){ref-type="ref"}, [48](#epi412307-bib-0048){ref-type="ref"}

Sx~c~ ^−^‐mediated CySS import has been demonstrated to be fundamental in maintaining the extracellular and intracellular redox balance (eg, GSH/GSSG and Cys/CySS), at least in vitro where growth of xCT‐deficient cells is dependent on the addition of a reducing agent.[49](#epi412307-bib-0049){ref-type="ref"} Of interest, dysregulation of glutathione homeostasis is associated with impairment of synaptic strength[13](#epi412307-bib-0013){ref-type="ref"}, [14](#epi412307-bib-0014){ref-type="ref"} and thus represents another possible explanation for the resistance of *SLC7A11* ^*sut/sut*^ mice to PTZ kindling. However, *SLC7A11* ^*sut/sut*^ mice have normal Cys, GSH, and GSSG levels in hippocampal and cortical tissue, although hippocampal CySS levels were found to be significantly decreased (Figure [4](#epi412307-fig-0004){ref-type="fig"}). Our data are in agreement with those of other studies in transgenic xCT nulls showing normal hippocampal GSH levels as compared to wild‐type mice.[10](#epi412307-bib-0010){ref-type="ref"} To our knowledge, this study is the first to measure the concentration of GSH in cortex as well as brain cyst(e)ine levels in a mouse null for Sx~c~ ^−^. Taken in toto, current and previous data in both transgenic xCT nulls and *SLC7A11* ^*sut/sut*^ mice suggest these animals must employ compensatory mechanisms (eg, EAAT3 or the alanine‐cysteine‐serine transporter \[ASCT1/2\] as alternative Cys transporters) to sustain GSH levels in vivo.

Finally, epileptogenic network sensitization and its resultant E/I imbalance is associated with synaptic reorganization, particularly when hilar neurons in the dentate gyrus are lost.[50](#epi412307-bib-0050){ref-type="ref"}, [51](#epi412307-bib-0051){ref-type="ref"} This reorganization includes reactive synaptogenesis of granule cell mossy fibers, whose targets have been demonstrated to include both excitatory[52](#epi412307-bib-0052){ref-type="ref"} and inhibitory[53](#epi412307-bib-0053){ref-type="ref"} neurons. However, we found no cellular loss in the hippocampus or cortex of PTZ‐kindled mice of either genotype (Figure [3](#epi412307-fig-0003){ref-type="fig"}). We also did not observe any significant hippocampal mossy fiber sprouting in any group tested, indicating that this structural alteration was not necessary for kindling development. These results are not unprecedented, as previous studies show that rats[54](#epi412307-bib-0054){ref-type="ref"} and guinea pigs[55](#epi412307-bib-0055){ref-type="ref"} kindle in the absence of mossy fiber sprouting. Moreover, suppression of reactive sprouting in rats[56](#epi412307-bib-0056){ref-type="ref"} and mice[57](#epi412307-bib-0057){ref-type="ref"} has been demonstrated to be ineffective in preventing epileptogenic neuronal sensitization following chemically induced status epilepticus.

In sum, our results demonstrate that *SLC7A11* ^*sut/sut*^ mice have a reduction in PTZ‐kindling acquisition that occurs in association with decreased GluA1 levels. Given the permissiveness of Sx~c~ ^−^ signaling to epileptogenesis---both glioma‐[21](#epi412307-bib-0021){ref-type="ref"}, [22](#epi412307-bib-0022){ref-type="ref"} and PTZ‐induced (this study)---we postulate that inhibition of astrocyte Sx~c~ ^−^ may represent an alternative therapeutic strategy to modulate excessive glutamatergic signaling in individuals predisposed to developing epilepsy.
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